MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$57,570K
Net Income
-$14,252K
Net Profit Margin
-24.76%
Unit: Thousand (K) dollars
Revenue Breakdown
ADHDPortfolio
EXXUAPortfolio
The Pediatric Portfolio
Product And Service Other
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Income Statement
2026-06-30
2025-06-30
Net revenue
57,570
66,382
Cost of goods sold
20,752
20,551
Gross profit
36,818
45,831
Selling and marketing
23,369
20,906
General and administrative
19,272
17,379
Research and development
0
1,326
Amortization of intangible assets
2,492
3,683
Restructuring costs
0
2,101
Impairment expense
0
8,263
Total operating expenses
45,133
53,658
Loss from operations
-8,315
-7,827
Other income (expense), net
713
-512
Interest expense
1,895
3,703
Derivative warrant liabilities loss
-4,734
-1,703
Loss on extinguishment of debt
-
0
Loss from continuing operations before income tax expense
-14,231
-13,745
Income tax expense
21
437
Net loss from continuing operations
-14,252
-14,182
Net income from discontinued operations, net of tax
0
620
Net loss
-14,252
-13,562
Basic EPS
-1.16
-2.16
Basic Average Shares
12,318,817
6,279,744
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
AYTU Income Statement Sankey Diagram
Sankey diagram visualizing AYTU income statement for the period
Net loss
-$14,252K
(-5.09%↓ Y/Y)
Net loss from
continuing operations
-$14,252K
(-0.49%↓ Y/Y)
ADHDPortfolio
$45,825K
EXXUAPortfolio
$6,574K
The Pediatric
Portfolio
$5,135K
Product And Service
Other
$36K
Loss from continuing
operations before income...
-$14,231K
(-3.54%↓ Y/Y)
Income tax expense
$21K
(-95.19%↓ Y/Y)
Other income
(expense), net
$713K
(239.26%↑ Y/Y)
Net revenue
$57,570K
(-13.27%↓ Y/Y)
Loss from operations
-$8,315K
(-6.23%↓ Y/Y)
Derivative warrant
liabilities loss
-$4,734K
(-177.98%↓ Y/Y)
Interest expense
$1,895K
(-48.83%↓ Y/Y)
Gross profit
$36,818K
(-19.67%↓ Y/Y)
Cost of goods sold
$20,752K
(0.98%↑ Y/Y)
Total operating
expenses
$45,133K
(-15.89%↓ Y/Y)
Selling and marketing
$23,369K
(11.78%↑ Y/Y)
General and
administrative
$19,272K
(10.89%↑ Y/Y)
Amortization of intangible
assets
$2,492K
(-32.34%↓ Y/Y)
Buy us a coffee
AYTU BIOPHARMA, INC (AYTU)
AYTU BIOPHARMA, INC (AYTU)